Cargando…

The Role of Lysosomes in a Broad Disease-Modifying Approach Evaluated across Transgenic Mouse Models of Alzheimer’s Disease and Parkinson’s Disease and Models of Mild Cognitive Impairment

Many neurodegenerative disorders have lysosomal impediments, and the list of proposed treatments targeting lysosomes is growing. We investigated the role of lysosomes in Alzheimer’s disease (AD) and other age-related disorders, as well as in a strategy to compensate for lysosomal disturbances. Compr...

Descripción completa

Detalles Bibliográficos
Autores principales: Hwang, Jeannie, Estick, Candice M., Ikonne, Uzoma S., Butler, David, Pait, Morgan C., Elliott, Lyndsie H., Ruiz, Sarah, Smith, Kaitlan, Rentschler, Katherine M., Mundell, Cary, Almeida, Michael F., Bear, Nicole Stumbling, Locklear, James P., Abumohsen, Yara, Ivey, Cecily M., Farizatto, Karen L.G., Bahr, Ben A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6770842/
https://www.ncbi.nlm.nih.gov/pubmed/31505809
http://dx.doi.org/10.3390/ijms20184432
_version_ 1783455577112838144
author Hwang, Jeannie
Estick, Candice M.
Ikonne, Uzoma S.
Butler, David
Pait, Morgan C.
Elliott, Lyndsie H.
Ruiz, Sarah
Smith, Kaitlan
Rentschler, Katherine M.
Mundell, Cary
Almeida, Michael F.
Bear, Nicole Stumbling
Locklear, James P.
Abumohsen, Yara
Ivey, Cecily M.
Farizatto, Karen L.G.
Bahr, Ben A.
author_facet Hwang, Jeannie
Estick, Candice M.
Ikonne, Uzoma S.
Butler, David
Pait, Morgan C.
Elliott, Lyndsie H.
Ruiz, Sarah
Smith, Kaitlan
Rentschler, Katherine M.
Mundell, Cary
Almeida, Michael F.
Bear, Nicole Stumbling
Locklear, James P.
Abumohsen, Yara
Ivey, Cecily M.
Farizatto, Karen L.G.
Bahr, Ben A.
author_sort Hwang, Jeannie
collection PubMed
description Many neurodegenerative disorders have lysosomal impediments, and the list of proposed treatments targeting lysosomes is growing. We investigated the role of lysosomes in Alzheimer’s disease (AD) and other age-related disorders, as well as in a strategy to compensate for lysosomal disturbances. Comprehensive immunostaining was used to analyze brains from wild-type mice vs. amyloid precursor protein/presenilin-1 (APP/PS1) mice that express mutant proteins linked to familial AD. Also, lysosomal modulation was evaluated for inducing synaptic and behavioral improvements in transgenic models of AD and Parkinson’s disease, and in models of mild cognitive impairment (MCI). Amyloid plaques were surrounded by swollen organelles positive for the lysosome-associated membrane protein 1 (LAMP1) in the APP/PS1 cortex and hippocampus, regions with robust synaptic deterioration. Within neurons, lysosomes contain the amyloid β 42 (Aβ42) degradation product Aβ38, and this indicator of Aβ42 detoxification was augmented by Z-Phe-Ala-diazomethylketone (PADK; also known as ZFAD) as it enhanced the lysosomal hydrolase cathepsin B (CatB). PADK promoted Aβ42 colocalization with CatB in lysosomes that formed clusters in neurons, while reducing Aβ deposits as well. PADK also reduced amyloidogenic peptides and α-synuclein in correspondence with restored synaptic markers, and both synaptic and cognitive measures were improved in the APP/PS1 and MCI models. These findings indicate that lysosomal perturbation contributes to synaptic and cognitive decay, whereas safely enhancing protein clearance through modulated CatB ameliorates the compromised synapses and cognition, thus supporting early CatB upregulation as a disease-modifying therapy that may also slow the MCI to dementia continuum.
format Online
Article
Text
id pubmed-6770842
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-67708422019-10-30 The Role of Lysosomes in a Broad Disease-Modifying Approach Evaluated across Transgenic Mouse Models of Alzheimer’s Disease and Parkinson’s Disease and Models of Mild Cognitive Impairment Hwang, Jeannie Estick, Candice M. Ikonne, Uzoma S. Butler, David Pait, Morgan C. Elliott, Lyndsie H. Ruiz, Sarah Smith, Kaitlan Rentschler, Katherine M. Mundell, Cary Almeida, Michael F. Bear, Nicole Stumbling Locklear, James P. Abumohsen, Yara Ivey, Cecily M. Farizatto, Karen L.G. Bahr, Ben A. Int J Mol Sci Article Many neurodegenerative disorders have lysosomal impediments, and the list of proposed treatments targeting lysosomes is growing. We investigated the role of lysosomes in Alzheimer’s disease (AD) and other age-related disorders, as well as in a strategy to compensate for lysosomal disturbances. Comprehensive immunostaining was used to analyze brains from wild-type mice vs. amyloid precursor protein/presenilin-1 (APP/PS1) mice that express mutant proteins linked to familial AD. Also, lysosomal modulation was evaluated for inducing synaptic and behavioral improvements in transgenic models of AD and Parkinson’s disease, and in models of mild cognitive impairment (MCI). Amyloid plaques were surrounded by swollen organelles positive for the lysosome-associated membrane protein 1 (LAMP1) in the APP/PS1 cortex and hippocampus, regions with robust synaptic deterioration. Within neurons, lysosomes contain the amyloid β 42 (Aβ42) degradation product Aβ38, and this indicator of Aβ42 detoxification was augmented by Z-Phe-Ala-diazomethylketone (PADK; also known as ZFAD) as it enhanced the lysosomal hydrolase cathepsin B (CatB). PADK promoted Aβ42 colocalization with CatB in lysosomes that formed clusters in neurons, while reducing Aβ deposits as well. PADK also reduced amyloidogenic peptides and α-synuclein in correspondence with restored synaptic markers, and both synaptic and cognitive measures were improved in the APP/PS1 and MCI models. These findings indicate that lysosomal perturbation contributes to synaptic and cognitive decay, whereas safely enhancing protein clearance through modulated CatB ameliorates the compromised synapses and cognition, thus supporting early CatB upregulation as a disease-modifying therapy that may also slow the MCI to dementia continuum. MDPI 2019-09-09 /pmc/articles/PMC6770842/ /pubmed/31505809 http://dx.doi.org/10.3390/ijms20184432 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Hwang, Jeannie
Estick, Candice M.
Ikonne, Uzoma S.
Butler, David
Pait, Morgan C.
Elliott, Lyndsie H.
Ruiz, Sarah
Smith, Kaitlan
Rentschler, Katherine M.
Mundell, Cary
Almeida, Michael F.
Bear, Nicole Stumbling
Locklear, James P.
Abumohsen, Yara
Ivey, Cecily M.
Farizatto, Karen L.G.
Bahr, Ben A.
The Role of Lysosomes in a Broad Disease-Modifying Approach Evaluated across Transgenic Mouse Models of Alzheimer’s Disease and Parkinson’s Disease and Models of Mild Cognitive Impairment
title The Role of Lysosomes in a Broad Disease-Modifying Approach Evaluated across Transgenic Mouse Models of Alzheimer’s Disease and Parkinson’s Disease and Models of Mild Cognitive Impairment
title_full The Role of Lysosomes in a Broad Disease-Modifying Approach Evaluated across Transgenic Mouse Models of Alzheimer’s Disease and Parkinson’s Disease and Models of Mild Cognitive Impairment
title_fullStr The Role of Lysosomes in a Broad Disease-Modifying Approach Evaluated across Transgenic Mouse Models of Alzheimer’s Disease and Parkinson’s Disease and Models of Mild Cognitive Impairment
title_full_unstemmed The Role of Lysosomes in a Broad Disease-Modifying Approach Evaluated across Transgenic Mouse Models of Alzheimer’s Disease and Parkinson’s Disease and Models of Mild Cognitive Impairment
title_short The Role of Lysosomes in a Broad Disease-Modifying Approach Evaluated across Transgenic Mouse Models of Alzheimer’s Disease and Parkinson’s Disease and Models of Mild Cognitive Impairment
title_sort role of lysosomes in a broad disease-modifying approach evaluated across transgenic mouse models of alzheimer’s disease and parkinson’s disease and models of mild cognitive impairment
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6770842/
https://www.ncbi.nlm.nih.gov/pubmed/31505809
http://dx.doi.org/10.3390/ijms20184432
work_keys_str_mv AT hwangjeannie theroleoflysosomesinabroaddiseasemodifyingapproachevaluatedacrosstransgenicmousemodelsofalzheimersdiseaseandparkinsonsdiseaseandmodelsofmildcognitiveimpairment
AT estickcandicem theroleoflysosomesinabroaddiseasemodifyingapproachevaluatedacrosstransgenicmousemodelsofalzheimersdiseaseandparkinsonsdiseaseandmodelsofmildcognitiveimpairment
AT ikonneuzomas theroleoflysosomesinabroaddiseasemodifyingapproachevaluatedacrosstransgenicmousemodelsofalzheimersdiseaseandparkinsonsdiseaseandmodelsofmildcognitiveimpairment
AT butlerdavid theroleoflysosomesinabroaddiseasemodifyingapproachevaluatedacrosstransgenicmousemodelsofalzheimersdiseaseandparkinsonsdiseaseandmodelsofmildcognitiveimpairment
AT paitmorganc theroleoflysosomesinabroaddiseasemodifyingapproachevaluatedacrosstransgenicmousemodelsofalzheimersdiseaseandparkinsonsdiseaseandmodelsofmildcognitiveimpairment
AT elliottlyndsieh theroleoflysosomesinabroaddiseasemodifyingapproachevaluatedacrosstransgenicmousemodelsofalzheimersdiseaseandparkinsonsdiseaseandmodelsofmildcognitiveimpairment
AT ruizsarah theroleoflysosomesinabroaddiseasemodifyingapproachevaluatedacrosstransgenicmousemodelsofalzheimersdiseaseandparkinsonsdiseaseandmodelsofmildcognitiveimpairment
AT smithkaitlan theroleoflysosomesinabroaddiseasemodifyingapproachevaluatedacrosstransgenicmousemodelsofalzheimersdiseaseandparkinsonsdiseaseandmodelsofmildcognitiveimpairment
AT rentschlerkatherinem theroleoflysosomesinabroaddiseasemodifyingapproachevaluatedacrosstransgenicmousemodelsofalzheimersdiseaseandparkinsonsdiseaseandmodelsofmildcognitiveimpairment
AT mundellcary theroleoflysosomesinabroaddiseasemodifyingapproachevaluatedacrosstransgenicmousemodelsofalzheimersdiseaseandparkinsonsdiseaseandmodelsofmildcognitiveimpairment
AT almeidamichaelf theroleoflysosomesinabroaddiseasemodifyingapproachevaluatedacrosstransgenicmousemodelsofalzheimersdiseaseandparkinsonsdiseaseandmodelsofmildcognitiveimpairment
AT bearnicolestumbling theroleoflysosomesinabroaddiseasemodifyingapproachevaluatedacrosstransgenicmousemodelsofalzheimersdiseaseandparkinsonsdiseaseandmodelsofmildcognitiveimpairment
AT locklearjamesp theroleoflysosomesinabroaddiseasemodifyingapproachevaluatedacrosstransgenicmousemodelsofalzheimersdiseaseandparkinsonsdiseaseandmodelsofmildcognitiveimpairment
AT abumohsenyara theroleoflysosomesinabroaddiseasemodifyingapproachevaluatedacrosstransgenicmousemodelsofalzheimersdiseaseandparkinsonsdiseaseandmodelsofmildcognitiveimpairment
AT iveycecilym theroleoflysosomesinabroaddiseasemodifyingapproachevaluatedacrosstransgenicmousemodelsofalzheimersdiseaseandparkinsonsdiseaseandmodelsofmildcognitiveimpairment
AT farizattokarenlg theroleoflysosomesinabroaddiseasemodifyingapproachevaluatedacrosstransgenicmousemodelsofalzheimersdiseaseandparkinsonsdiseaseandmodelsofmildcognitiveimpairment
AT bahrbena theroleoflysosomesinabroaddiseasemodifyingapproachevaluatedacrosstransgenicmousemodelsofalzheimersdiseaseandparkinsonsdiseaseandmodelsofmildcognitiveimpairment
AT hwangjeannie roleoflysosomesinabroaddiseasemodifyingapproachevaluatedacrosstransgenicmousemodelsofalzheimersdiseaseandparkinsonsdiseaseandmodelsofmildcognitiveimpairment
AT estickcandicem roleoflysosomesinabroaddiseasemodifyingapproachevaluatedacrosstransgenicmousemodelsofalzheimersdiseaseandparkinsonsdiseaseandmodelsofmildcognitiveimpairment
AT ikonneuzomas roleoflysosomesinabroaddiseasemodifyingapproachevaluatedacrosstransgenicmousemodelsofalzheimersdiseaseandparkinsonsdiseaseandmodelsofmildcognitiveimpairment
AT butlerdavid roleoflysosomesinabroaddiseasemodifyingapproachevaluatedacrosstransgenicmousemodelsofalzheimersdiseaseandparkinsonsdiseaseandmodelsofmildcognitiveimpairment
AT paitmorganc roleoflysosomesinabroaddiseasemodifyingapproachevaluatedacrosstransgenicmousemodelsofalzheimersdiseaseandparkinsonsdiseaseandmodelsofmildcognitiveimpairment
AT elliottlyndsieh roleoflysosomesinabroaddiseasemodifyingapproachevaluatedacrosstransgenicmousemodelsofalzheimersdiseaseandparkinsonsdiseaseandmodelsofmildcognitiveimpairment
AT ruizsarah roleoflysosomesinabroaddiseasemodifyingapproachevaluatedacrosstransgenicmousemodelsofalzheimersdiseaseandparkinsonsdiseaseandmodelsofmildcognitiveimpairment
AT smithkaitlan roleoflysosomesinabroaddiseasemodifyingapproachevaluatedacrosstransgenicmousemodelsofalzheimersdiseaseandparkinsonsdiseaseandmodelsofmildcognitiveimpairment
AT rentschlerkatherinem roleoflysosomesinabroaddiseasemodifyingapproachevaluatedacrosstransgenicmousemodelsofalzheimersdiseaseandparkinsonsdiseaseandmodelsofmildcognitiveimpairment
AT mundellcary roleoflysosomesinabroaddiseasemodifyingapproachevaluatedacrosstransgenicmousemodelsofalzheimersdiseaseandparkinsonsdiseaseandmodelsofmildcognitiveimpairment
AT almeidamichaelf roleoflysosomesinabroaddiseasemodifyingapproachevaluatedacrosstransgenicmousemodelsofalzheimersdiseaseandparkinsonsdiseaseandmodelsofmildcognitiveimpairment
AT bearnicolestumbling roleoflysosomesinabroaddiseasemodifyingapproachevaluatedacrosstransgenicmousemodelsofalzheimersdiseaseandparkinsonsdiseaseandmodelsofmildcognitiveimpairment
AT locklearjamesp roleoflysosomesinabroaddiseasemodifyingapproachevaluatedacrosstransgenicmousemodelsofalzheimersdiseaseandparkinsonsdiseaseandmodelsofmildcognitiveimpairment
AT abumohsenyara roleoflysosomesinabroaddiseasemodifyingapproachevaluatedacrosstransgenicmousemodelsofalzheimersdiseaseandparkinsonsdiseaseandmodelsofmildcognitiveimpairment
AT iveycecilym roleoflysosomesinabroaddiseasemodifyingapproachevaluatedacrosstransgenicmousemodelsofalzheimersdiseaseandparkinsonsdiseaseandmodelsofmildcognitiveimpairment
AT farizattokarenlg roleoflysosomesinabroaddiseasemodifyingapproachevaluatedacrosstransgenicmousemodelsofalzheimersdiseaseandparkinsonsdiseaseandmodelsofmildcognitiveimpairment
AT bahrbena roleoflysosomesinabroaddiseasemodifyingapproachevaluatedacrosstransgenicmousemodelsofalzheimersdiseaseandparkinsonsdiseaseandmodelsofmildcognitiveimpairment